Nanomedicine for uterine leiomyoma therapy

Keyphrases

• Nanoparticles 100%
• Uterine Leiomyoma 100%
• Nanomedicine 100%
• Drug Release 66%
• Leiomyoma Cells 66%
• Cell Morphology 33%
• Cytotoxicity 33%
• Anticancer Drugs 33%
• Confocal Imaging 33%
• In Vitro Cytotoxicity 33%
• Hormone-dependent 33%
• Hysterectomy 33%
• X Ray Diffraction 33%
• Drug Loading 33%
• Cellular Uptake 33%
• Women of Reproductive Age 33%
• 2-methoxyestradiol 33%
• Fertility-preserving 33%
• Excellent Long-term Stability 33%
• Differential Scanning Calorimetry 33%
• Polymeric Nanoparticles 33%
• Polylactic Acid 33%
• Encapsulation Efficiency 33%
• Fluorescent Nanoparticles 33%
• High Encapsulation Efficiency 33%
• Fibroids 33%
• Free Drug 33%
• Poly(lactic-co-glycolic acid) Nanoparticles 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Nanoparticle 100%
• Uterus Myoma 100%
• Nanomedicine 100%
• Drug Release 33%
• Leiomyoma 33%
• Cytotoxicity 33%
• High Performance Liquid Chromatography 16%
• Confocal Microscopy 16%
• Anticarcinogen 16%
• Polyglactin 16%
• Differential Scanning Calorimetry 16%
• 2-Methoxyestradiol 16%
• Polylactic Acid 16%